There are 2867 resources available
1262TiP - Efficacy and safety of consolidative camrelizumab following definitive concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell cancer
Presenter: Jun Wang
Session: Poster session 17
1297P - Adjuvant gemcitabine is as efficient as mFOLFIRINOX in patients with GemPred+ tumor signature and resected pancreatic adenocarcinoma (PDAC): An ancillary study of the PRODIGE-24 clinical trial
Presenter: Remy Nicolle
Session: Poster session 17
1298P - Extended overall survival results from the POLO study of active maintenance olaparib in patients with metastatic pancreatic cancer and a germline BRCA mutation
Presenter: Pascal Hammel
Session: Poster session 17
1299P - PD-1 blockade plus chemotherapy followed by concurrent hypofractionated radiotherapy with simultaneous integrated boost as induction therapy for patients with borderline resectable and locally advanced pancreatic cancer: A phase II clinical trial
Presenter: Juan Du
Session: Poster session 17
1300P - Exploration of a novel HRD signature (HRDsig) as a biomarker of first line FOLFIRINOX benefit in metastatic pancreatic cancer
Presenter: Aatur Singhi
Session: Poster session 17
1301P - Sequential therapy of metastatic pancreatic ductal adenocarcinoma (PDAC) after failure of gemcitabine plus nab-paclitaxel with either 5-FU/folinic acid (5FU/LV) plus irinotecan (FOLFIRI) followed by 5FU/LV plus oxaliplatin (OFF) or the reverse sequence: The PANTHEON trial (AIO PAK 0116)
Presenter: Dominik Modest
Session: Poster session 17
1302P - Gender differences in tumor characteristics, treatment allocation and survival in patients in a real-world non-metastatic pancreatic cancer cohort
Presenter: Anne Gehrels
Session: Poster session 17
1303P - Feasibility of endoscopic ultrasound-guided fine needle biopsy tissue sampling for whole exome sequencing in pancreatic cancer
Presenter: Soomin Yang
Session: Poster session 17
1304P - Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer
Presenter: Fergus Keane
Session: Poster session 17
1305P - Landscape and clinical significance of germline pathogenic variants (PV) in pancreatic cancer (PC)-predisposing genes in PC patients
Presenter: Annalice Gandini
Session: Poster session 17